Cargando…
Comments: Absolute cardiovascular risk assessment for guiding antihypertensive prescribing in Australian primary care patients with hypertension
Autores principales: | Bezabhe, Woldesellassie M., Peterson, Gregory M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256604/ https://www.ncbi.nlm.nih.gov/pubmed/35794215 http://dx.doi.org/10.1038/s41371-022-00719-4 |
Ejemplares similares
-
Medication Prescribing Quality in Australian Primary Care Patients with Chronic Kidney Disease
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2020) -
Ten-Year Trends in Psychotropic Prescribing and Polypharmacy in Australian General Practice Patients with and without Dementia
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2023) -
Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes
por: Bezabih, Yihienew M., et al.
Publicado: (2021) -
Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial Fibrillation
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2021) -
Oral Anticoagulant Discontinuation and Its Predictors in Patients with Atrial Fibrillation
por: Kefale, Adane Teshome, et al.
Publicado: (2022)